Gene · 10460
Papers1,759
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,759
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predicting Infertility: How Genetic Variants in Oocyte Spindle Genes Affect Egg Quality. | Adv Anat Embryol Cell Biol | 2024 | 39030352 | PubTator, text mining | PubMed |
| Moxibustion Promoted Axonal Regeneration and Improved Learning and Memory of Post-stroke Cognitive Impairment by Regulating PI3K/AKt and TACC3. | Neuroscience | 2024 | 38848775 | PubTator, text mining | PubMed |
| TARGET: A phase I/II open-label multicenter study to assess safety and efficacy of fexagratinib in patients with relapsed/refractory FGFR fusion-positive glioma. | Neurooncol Adv | 2024 | 38813112 | PubTator, text mining | PubMed |
| PI3K/HSCB axis facilitates FOG1 nuclear translocation to promote erythropoiesis and megakaryopoiesis. | Elife | 2024 | 38757931 | PubTator, text mining | PubMed |
| Liquid-liquid phase separation of microtubule-binding proteins in the regulation of spindle assembly. | Cell Prolif | 2024 | 38736355 | PubTator, text mining | PubMed |
| Retraction Notice to: Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma. | Mol Ther | 2024 | 38701794 | PubTator, text mining | PubMed |
| Patient with mediastinal carcinoma of unknown primary with RET fusion achieves durable response with RET inhibition. | Anticancer Drugs | 2024 | 38696710 | PubTator, text mining | PubMed |
| Cellular senescence gene TACC3 associated with colorectal cancer risk via genetic and DNA methylated alteration. | Arch Toxicol | 2024 | 38480537 | PubTator, text mining | PubMed |
| PAK1-Dependent Regulation of Microtubule Organization and Spindle Migration Is Essential for the Metaphase I-Metaphase II Transition in Porcine Oocytes. | Biomolecules | 2024 | 38397472 | PubTator, text mining | PubMed |
| Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. | Cancer Res | 2024 | 38319231 | PubTator, text mining | PubMed |
| Differences in methylation profiles between long-term survivors and short-term survivors of IDH-wild-type glioblastoma. | Neurooncol Adv | 2024 | 38312227 | PubTator, text mining | PubMed |
| Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancer. | Genes Dis | 2024 | 38292185 | PubTator, text mining | PubMed |
| Systematic identification of 20S proteasome substrates. | Mol Syst Biol | 2024 | 38287148 | PubTator, text mining | PubMed |
| Atypical Histopathological Aspects of Common Types of Lung Cancer-Our Experience and Literature Review. | Medicina (Kaunas) | 2024 | 38256374 | PubTator, text mining | PubMed |
| Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers. | Int J Mol Sci | 2024 | 38255923 | PubTator, text mining | PubMed |
| Clinicopathological and Molecular Characteristics of IDH-Wildtype Glioblastoma with FGFR3::TACC3 Fusion. | Biomedicines | 2024 | 38255255 | PubTator, text mining | PubMed |
| Regulation of Angiogenesis by Non-Coding RNAs in Cancer. | Biomolecules | 2024 | 38254660 | PubTator, text mining | PubMed |
| The Mechanisms of Regulated Cell Death: Structural and Functional Proteomic Pathways Induced or Inhibited by a Specific Protein-A Narrative Review. | Proteomes | 2024 | 38250814 | PubTator, text mining | PubMed |
| How to Defeat Multidrug-Resistant Bacteria in Intensive Care Units. A Lesson from the COVID-19 Pandemic. Prevention, Reservoirs, and Implications for Clinical Practice. | Int J Med Sci | 2024 | 38250609 | PubTator, text mining | PubMed |
| The important regulatory roles of circRNA‑encoded proteins or peptides in cancer pathogenesis (Review). | Int J Oncol | 2024 | 38186313 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10460/papers?page=6